Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New Clot-Busting device tested in 500 patients

NCT ID NCT05868161

Disease control Sponsor: SurModics, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is tracking 500 people who had a procedure using the Pounce Thrombectomy System, a device that removes blood clots from arteries in the legs without open surgery. The goal is to see how well the device restores blood flow and how safe it is. The study is retrospective, meaning it looks back at medical records, and is being conducted at multiple centers in the US.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Pounce Thrombectomy System (a device that removes blood clots from arteries without open surgery)
What this could lead to
If successful, this registry could confirm that the Pounce device is a safe and effective way to restore blood flow in people with blocked leg arteries, potentially reducing the need for more invasive surgery.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove the device works better than other treatments. Results may be influenced by patient selection and lack of a comparison group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2023

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult subjects who have had an endovascular intervention where use of the Pounce Thrombectomy System was attempted

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subject underwent an endovascular intervention where the Pounce Thrombectomy System was attempted * Subject is willing and able to provide informed consent prior to the collection of study data or a consent waiver is in place Exclusion Criteria: * Subject is under the age of 18 years

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute limb ischemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

limb ischemia peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute limb ischemia Peripheral arterial disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    7 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Allina Health

    COMPLETED

    Minneapolis, Minnesota, 55407, United States

  • Ascension Seton

    RECRUITING

    Austin, Texas, 78723, United States

  • Baton Rouge General Medical Center

    RECRUITING

    Baton Rouge, Louisiana, 70809, United States

  • Cleveland Clinic

    RECRUITING

    Cleveland, Ohio, 44195, United States

  • Community Hospital

    COMPLETED

    Munster, Indiana, 46321, United States

  • North Central Heart

    RECRUITING

    Sioux Falls, South Dakota, 57108, United States

  • OSF St. Francis Medical Center

    RECRUITING

    Peoria, Illinois, 61637, United States

  • Prisma Health Upstate

    RECRUITING

    Greenville, South Carolina, 29601, United States

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37212, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.